Guardian Pharmacy Services, Inc. $GRDN Shares Bought by Quantbot Technologies LP

Quantbot Technologies LP raised its holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 233.4% during the 3rd quarter, Holdings Channel.com reports. The firm owned 33,486 shares of the company’s stock after acquiring an additional 23,443 shares during the period. Quantbot Technologies LP’s holdings in Guardian Pharmacy Services were worth $878,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in GRDN. Ameritas Investment Partners Inc. raised its stake in shares of Guardian Pharmacy Services by 26.5% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after buying an additional 345 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Guardian Pharmacy Services by 7.1% in the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock worth $258,000 after buying an additional 805 shares during the last quarter. Police & Firemen s Retirement System of New Jersey boosted its stake in shares of Guardian Pharmacy Services by 76.8% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after buying an additional 1,062 shares during the last quarter. State of Alaska Department of Revenue acquired a new stake in Guardian Pharmacy Services during the third quarter worth about $30,000. Finally, Parkside Financial Bank & Trust grew its holdings in Guardian Pharmacy Services by 70.5% during the third quarter. Parkside Financial Bank & Trust now owns 3,248 shares of the company’s stock worth $85,000 after acquiring an additional 1,343 shares during the period.

Analyst Upgrades and Downgrades

GRDN has been the subject of a number of analyst reports. Wall Street Zen raised Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Stephens boosted their target price on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a research note on Wednesday, January 14th. Finally, Truist Financial increased their price target on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Guardian Pharmacy Services presently has a consensus rating of “Moderate Buy” and a consensus price target of $32.00.

Guardian Pharmacy Services Trading Down 6.1%

Shares of GRDN opened at $31.88 on Friday. The firm has a market cap of $2.02 billion, a P/E ratio of 50.60 and a beta of 0.86. Guardian Pharmacy Services, Inc. has a 12 month low of $17.78 and a 12 month high of $37.43. The stock’s 50 day moving average is $31.63 and its two-hundred day moving average is $29.14.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.